ACURA PHARMACEUTICALS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAcura Pharmaceuticals, Inc • April 18th, 2013 • Pharmaceutical preparations • New York
Company FiledApril 18th, 2013 Industry JurisdictionAcura Pharmaceuticals, Inc., a New York corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: